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19th CardioVascular Summit: TCTAP 2014[Interventional Management]
Procedural step:
1. After ETGA, a CVC line is inserted through left internal jugular vein and a
temporary pacemaker through right internal jugular vein
2. Left femoral artery picture with a 6Fr sheath inserted
3. Right femoral artery cut-down with 18Fr. sheath inserted
4. Inserted a Amplatz superstiff 260cm in to LV as guidewire (0.35" Stiff-
terumo into LV via a AL1 diagnostic catheter -> change to J-tipped
guidewire -> insert a pig-tail catheter into LV -> insert the Amplatz Super-
stiff wire)
5. Aortic valvuloplaty with Nucleus 20 x 40mm, under rapid pacing up to
180bpm
6. Deploy Medtronic CoreValve 29mm
7. Post-dilataion with NuMed 25 x 40mm
8. The 1st CoreVavle poped out while retrieving the wire
9. No PG across the dislodged valve and the aortic branch compromised
10. TEE showed no dissection
11. Deploy a 2nd Medtronic CoreValve 29mm
12. No LV-Ao pressure gradient
13. Close RFA wound layer by layerS208 JACC Vol 63/12/Suppl S jCase Summary:
This is a 93-year-old male, with severe aortic stenosis and underwent TAVI in Aug.
2013. After the post-deploy dilation of the ﬁrst Core Valve, the proximal stent strut
was deformed and the Valve was retracted while drawing the wire, as the wire passing
from outer stent side through a strut into the stent. The ﬁrst valve was placed right at
the aortic arch and a second Core Valve was later deployed successfully. The patient’s
condition improved after the procedure and there was no related complication.
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[Clinical Information]
Patient initials or identiﬁer number:
Rabeya
[Interventional Management]
Procedural step:
A 71 year-old woman with known mitral stenosis (MS) admitted on 19.01.2013 in
National Institute of Cardiovascular Disease (NICVD), Dhaka with history of palpi-
tation and dyspnea on exertion for several years. On examination, her blood pressure
was 100/70 mm Hg and her heart rate was 72 per minute, irregular. JVP is raised with
absent a wave. There was a tapping apex beat, palpable P2 and a diastolic thrill over
the apical area. The 1st and the pulmonary component of the 2nd heart sounds were
loud, and a low-pitched, localized, mid diastolic murmur of grade 4/6 was heard over
the apical area. Total leukocyte count was 10400/mm3, erythrocyte sedimentation rate
18 mm in 1st hour, hemoglobin 10.8 gm/dL, C-reactive protein negative, anti-strep-
tolysin O (ASO) titer <200 IU, bleeding time 3.15 minutes, clotting time 5.45 mi-
nutes, prothrombin time was normal. In ECG heart rate was 80/min with atrial
ﬁbrillation. Chest X-ray showed straightening of the left cardiac border, widen angle
of carina, double counter right border. Echocardiography revealed severe mitral ste-
nosis due to chronic rheumatic heart disease with mitral valve area (MVA) 0.9cm2,
mildly dilated left atrium (44 mm), with pulmonary artery systolic pressure (PASP)
41mm Hg. Doppler studies showed a peak mitral valve gradient (MVG) 21mm of Hg.
Trivial MR, moderate tricuspid regurgitation, normal left ventricular (LV) size with
ejection fraction (EF) 63%, no left atrium (LA) thrombus, and mitral valve Willkin’s
score was 7. Coronary angiogram (CAG) was done before PTMC and was found
normal epicardial coronary vessel. PTMC was done successfully through right femoral
vein approach. Left atrial pressure fall down from 38/18/25 mm of Hg (systolic/dia-
stolic/mean) to 22/10/15 mm of Hg (systolic/diastolic/mean). Before PTMC aortic
pressure was 100/80/90 mm of Hg (systolic/diastolic/mean) after 110/85/95 mm of Hg
(systolic/diastolic/mean). Whole procedure and the postoperative period were un-
eventful. Patient was discharged on 4th postoperative day and followed up after
5 months. She had no palpitation and shortness of breath. Follow up echocardiography
showed MVA-1.8-2.0 cm2 with trivial MR. MVG 6.07mm of Hg PASP 36 mm of Hg.
No vegetation or thrombus.LV systolic function was good.April 22–25, 2014 j TCTAP Abstracts/CASE/Valvular Heart Disease
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19th CardioVascular Summit: TCTAP 2014Case Summary:
Rheumatic mitral stenosis (MS) is a progressive disease and without treatment it carries
signiﬁcant mortality and morbidity. The mitral valve (MV) is the most frequently
affected valve in chronic rheumatic heart disease. It is solely affected in 25% and about
40% have combined mitral stenosis and mitral regurgitation (MR), multivalve
involvement is seen in 38% of MS patient. All symptomatic patients should undergo
intervention to improve cardiac function as well as to prevent complication.
Inoue K and colleagues were the ﬁrst to perform percutaneous transvenous mitral
commissurotomy (PTMC) in 1982. Since then PTMC became a standard procedure to
help patients with MS favorable for it and tends to delay the need for MV replacement
for about ten years or more PTMC is of maximum beneﬁts in patient with pliable
mitral valve, fused and restricted commissures without calciﬁcation or ﬁbrosis
assessed by using Wilkins criteria. In general, patients with a Wilkins score of <9 and
less than moderate mitral regurgitation has the best outcomes, although many patients
have beneﬁted from PTMC despite higher valve scores.
Although reports regarding safety and efﬁcacy of PTMC in older children andyoung adult
are available but there are limited data about PTMC in elderly people. We have done
PTMC successfully in a 71 years old femalewhich is theﬁrst reported case inBangladesh.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/CASTCTAP C-234
Early Core Valve Stenosis Due to Extensive Calciﬁcation in a Patient with
Dialysis-dependent Chronic Renal Failure
Rajesh K. Nair, Adam El Gamel, John Newland, Peace Tamuno, Sanjeevan Pasupati
Waikato Hospital, New Zealand
[Clinical Information]
Patient initials or identiﬁer number:
BR
Relevant clinical history and physical exam:
65 Years old man with severe symptomatic aortic stenosis was referred for consid-
eration of transcatheter aortic valve implant (TAVI). He was on haemodialysis for end
stage renal failure secondary to obstructive uropathy and chronic urosepsis. His other
co-morbidities included ischaemic heart disease with previous angioplasty to LAD,
secondary hyperparathyroidism, and previous pan colectomy for steroid-dependent
ulcerative colitis.
Cardiovascular examination revealed normal jugular venous pulsation and a slow rising
carotid pulse. Heart sounds were dual with a loud ejection systolic murmur consistent
with aortic stenosis. There was no clinical evidence of overt left or right heart failure.
Relevant test results prior to catheterization:
Routine complete blood count was normal.
His ECG showed normal sinus rhythm with no evidence of heart block.
Transthoracic echocardiography revealed severe aortic stenosis - aortic valve area
0.7cm2 mean gradient of 75mmHg and peak gradient of 110mHg. Left ventricular
systolic function was normal.
Relevant catheterization ﬁndings:
Coronary angiography revealed mild in-stent restenosis of the LAD stent with no
ﬂow-limiting disease elsewhere. Right heart catheterisation revealed normal pulmo-
nary pressures.
[Interventional Management]
Procedural step:
Patient had bridging balloon aortic valvuloplasty two months prior to TAVI.
TAVI procedure steps:
1. A balloon tipped temporary pacing wire was inserted through the right internal
jugular vein into the right ventricle.
2. A 6 French sheath was inserted in the left femoral artery. Through this sheath
a marker pigtail catheter was advanced and placed in the aortic root.
3. Under direct vision a 10 French sheath was inserted in the right femoral artery
and a Prostar was implanted. Following this the sheath was upsized to an 18
French sheath
4. An aortogram was performed to assess the annular plane, following which the
aortic valve was crossed. Simultaneous pressures were then obtained.
5. A 22 x 40mm Numed nucleus balloon was used to perform one inﬂation under
rapid RV pacing at 180bpm with excellent stability.
6. A 29mm Medtronic CoreValve in the AccuTrak system was deployed across
the aortic annulus. Fluoroscopic views showed excellent position
6. The aortic valve was crossed again and simultaneous pressure gradients were
obtained. Aortic peak gradient pre-TAVI was 48mmHg and dropped to
12mmHg post TAVI; the pre-TAVI mean gradient was 40mmHg and dropped
to 5mmHg post procedure.
7. The right femoral artery access was closed with the Prostar device. A contra-
lateral injection was performed to ensure there was no extravasation of blood.E/Valvular Heart Disease S209
